Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis

Veterinary Dermatology

Volumn 24, Issue 3, 2013, Pages

  Santoro, Domenico ^a   Marsella, Rosanna ^b   Ahrens, Kim ^b   Graves, Thomas K ^a   Bunick, David ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN; INTERMEDIATE FILAMENT PROTEIN; MESSENGER RNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; CASE CONTROL STUDY; DOG; DOG DISEASE; FEMALE; GENETICS; MALE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; SKIN;

ANIMALS; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; FEMALE; INTERMEDIATE FILAMENT PROTEINS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN;

EID: 84877878182     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/vde.12031     Document Type: Article

References (52)

1. Bieber T. Atopic dermatitis. Ann Dermatol 2010; 22: 125-137.
2. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Vet Immunol Immunopathol 2001; 81: 147-151.
3. Elias PM, Steinhoff M. "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008; 128: 1067-1070.
4. Proksch E, Folster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006; 43: 159-169.
5. Pilgram GS, Vissers DC, van der Meulen H et al. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001; 117: 710-717.
6. Wolf R, Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol 2012; 30: 329-334.
7. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 2012; 122: 440-447.
8. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999; 31: 5-19.
9. Chen H, Common JE, Haines RL et al. Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singapore Chinese and European populations. Br J Dermatol 2011; 165: 106-114.
10. Kawasaki H, Kubo A, Sasaki T et al. Loss-of-function mutations within the filaggrin gene and atopic dermatitis. Curr Probl Dermatol 2011; 41: 35-46.
11. Lesiak A, Kuna P, Zakrzewski M et al. Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis. Exp Dermatol 2011; 20: 491-495.
12. Weidinger S, Rodríguez E, Stahl C et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007; 127: 724-726.
13. Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 2010; 58: 1-7.
14. Henderson J, Northstone K, Lee SP et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008; 121: 872-877.e9.
15. Bieber T, Novak N. Pathogenesis of atopic dermatitis: new developments. Curr Allergy Asthma Rep 2009; 9: 291-294.
16. Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120: 150-155.
17. Marsella R, Olivry T. Animal models of atopic dermatitis. Clin Dermatol 2003; 21: 122-133.
18. Willemse T. Comparative aspects of canine and human atopic dermatitis. Semin Vet Med Surg (Small Animal) 1988; 3: 255.
19. Helton Rhodes K, Kerdel F, Soter NA. Comparative aspects of canine and human atopic dermatitis. Sem Vet Med Surg (Small Animal) 1987; 2: 166-172.
20. Marsella R, Olivry T, Nicklin C et al. Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs. Vet Dermatol 2006; 17: 24-35.
21. Marsella R, Girolomoni G. Canine models of atopic dermatitis: a useful tool with untapped potential. J Invest Dermatol 2009; 129: 2351-2357.
22. Chervet L, Galichet A, McLean WH et al. Missing C-terminal filaggrin expression, NFkappaB activation and hyperproliferation identify the dog as a putative model to study epidermal dysfunction in atopic dermatitis. Exp Dermatol 2010; 19: e343-e346.
23. Marsella R, Samuelson D, Harrington L. Immunohistochemical evaluation of filaggrin polyclonal antibody in atopic and normal beagles. Vet Dermatol 2009; 20: 547-554.
24. Roque JB, O'Leary CA, Kyaw-Tanner M et al. Real-time PCR quantification of the canine filaggrin orthologue in the skin of atopic and non-atopic dogs: a pilot study. BMC Res Notes 2011; 4: 554.
25. Wood SH, Ollier WE, Nuttall T et al. Despite identifying some shared gene associations with human atopic dermatitis the use of multiple dog breeds from various locations limits detection of gene associations in canine atopic dermatitis. Vet Immunol Immunopathol 2010; 138: 193-197.
26. Suriyaphol G, Suriyaphol P, Sarikaputil M et al. Association of filaggrin (FLG) gene polymorphism with canine atopic dermatitis in small breed dogs. Thai J Vet Med 2011; 41: 509-517.
27. Olivry T. What can dogs bring to atopic dermatitis research? Chem Immunol Allergy 2012; 96: 61-72.
28. Marsella R, Olivry T, Carlotti DN; International Task Force on Canine Atopic Dermatitis. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Vet Dermatol 2011; 22: 239-248.
29. Marsella R, Santoro D, Ahrens K et al. Investigation of the effect of probiotic exposure on filaggrin expression in an experimental model of canine atopic dermatitis. Vet Dermatol 2013; 24: 260-e57.
30. Marsella R. Does filaggrin expression correlate with severity of clinical signs in dogs with atopic dermatitis? Vet Dermatol 2013; 24: 266-e59.
31. Marsella R, Messinger L, Zabel S et al. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis. Vet Dermatol 2010; 21: 50-57.
32. Olivry T, Marsella R, Iwasaki T et al.; International Task Force On Canine Atopic Dermatitis. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 2007; 18: 78-86.
33. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: 2002-2007.
34. Santoro D, Bunick D, Graves TK et al. Expression and distribution of antimicrobial peptides in the skin of healthy beagles. Vet Dermatol 2011; 22: 61-67.
35. Osawa R, Akiyama M, Shimizu H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int 2011; 60: 1-9.
36. Theerawatanasirikul S, Sailasuta A, Thanawongnuwech R et al. Alterations of keratins, involucrin and filaggrin gene expression in canine atopic dermatitis. Res Vet Sci 2012; 93: 1287-1292.
37. Yoon JS, Nishifuji K, Sasaki A et al. Alteration of stratum corneum ceramide profiles in spontaneous canine model of atopic dermatitis. Exp Dermatol 2011; 20: 732-736.
38. Shimada K, Yoon JS, Yoshihara T et al. Increased transepidermal water loss and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis. Vet Dermatol 2009; 20: 541-554.
39. Reiter LV, Torres SM, Wertz PW. Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls. Vet Dermatol 2009; 20: 260-266.
40. Tan SP, Abdul-Ghaffar S, Weller RB et al. Protease-antiprotease imbalance may be linked to potential defects in profilaggrin proteolysis in atopic dermatitis. Br J Dermatol 2012; 166: 1137-1140.
41. Barros Roque J, O'Leary CA, Kyaw-Tanner M et al. Haplotype sharing excludes canine orthologous filaggrin locus in atopy in West Highland white terriers. Anim Genet 2009; 40: 793-794.
42. Salzmann CA, Olivry TJ, Nielsen DM et al. Genome-wide linkage study of atopic dermatitis in West Highland White terriers. BMC Genet 2011; 12: 37.
43. Gutowska-Owsiak D, Schaupp AL, Salimi M et al. Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes. Br J Dermatol 2011; 165: 492-498.
44. McPherson T, Sherman VJ, Aslam A et al. Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema. Br J Dermatol 2010; 163: 544-549.
45. Nuttall TJ, Knight PA, McAleese SM et al. T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis. Vet Immunol Immunopathol 2002; 87: 379-384.
46. Törmä H, Lindberg M, Berne B. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol 2008; 128: 1212-1219.
47. O'Regan GM, Sandilands A, McLean WH et al. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2009; 124: R2-R6.
48. Hvid M, Johansen C, Deleuran B et al. Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines - a possible link between reduced skin barrier function and inflammation? Exp Dermatol 2011; 20: 633-636.
49. Wu Z, Hansmann B, Meyer-Hoffert U et al. Molecular identification and expression analysis of filaggrin-2, a member of the S100 fused-type protein family. PLoS ONE 2009; 4: e5227.
50. Hansmann B, Ahrens K, Wu Z et al. Murine filaggrin-2 is involved in epithelial barrier function and down-regulated in metabolically induced skin barrier dysfunction. Exp Dermatol 2012; 21: 271-276.
51. Kanda S, Sasaki T, Shiohama A et al. Characterization of canine filaggrin: gene structure and protein expression in dog skin. Vet Dermatol 2013; 24: 25-e7.
52. Burgess A, Vigneron S, Brioudes E et al. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci USA 2010; 107: 12564-12569.